Retrosynthesis AI

Retrosynthesis AI is the use of software and AI to propose synthetic routes by working backward from a target molecule. In Data, AI, and Scientific Research: A Coffee Chat, Mossam describes it as an extension of traditional retrosynthesis, using published reaction information to suggest plans that chemists can evaluate and attempt in the lab.

The source treats the area as promising but not self-validating. Machine-designed synthetic plans may become hard to distinguish from human-designed ones in blind comparisons, but they still need Experimental Science Data Quality, reproducible lab execution, and Human-Driven Scientific AI oversight before they count as useful chemistry.

Key Claims

• Retrosynthesis starts with the target molecule and works backward toward available precursors.
• AI systems can use published reactions to propose plausible routes.
• Blind route comparisons suggest AI can already produce plans that look chemist-like in some cases.
• Published reaction data is incomplete when failed reactions and negative results are omitted.
• Synthetic-route generation still requires human chemists to judge feasibility, safety, novelty, and reproducibility.

Connections

• Mossam (Data Science With Sam) - source speaker explaining the concept.
• AI For Science, AI Drug Discovery Platform, and Generative Biology - broader AI chemistry and drug-discovery context.
• Radiochemistry Imaging Tracers, Blood-Brain Barrier Prediction, and Negative Results As Scientific Data - source-adjacent chemistry branches.
• Experimental Science Data Quality, AI Verification, and Domain Expert Alignment - constraints on useful deployment.